Frontlight ResearchEarly access
Myasthenia gravis trials in United States
20 of 52 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Where
- Austin, Boca Raton, Boston, Charleston, Detroit, Greenfield, Iowa City, Jacksonville Beach, Kansas City, Louisville, O'Fallon, Port Charlotte, Portland, San Francisco, St. Petersburg
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- argenx
See details and how to joinNCT06298565 - No phaseTaking peopleRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
- Where
- Sioux Falls
- People
- 20,000
- Run by
- Sanford Health
See details and how to joinNCT01793168 - No phaseTaking peopleADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Where
- Amherst, Austin, Boston, Carlsbad, Chapel Hill, Chattanooga, Cincinnati, Columbus, Detroit, Durham, Las Vegas, Miami, San Antonio, Tampa
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- argenx
See details and how to joinNCT07294170 - No phaseNot yet taking people in United StatesQuantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG
- Where
- Boston
- Age
- 18 years to 80 years
- People
- 25
- Run by
- BioSensics
See details and how to joinNCT07226830 - No phaseTaking peopleFeasibility of Remote Monitoring of Patients With Myasthenia Gravis
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 18
- Run by
- George Washington University
See details and how to joinNCT07787247 - No phaseEnrolling by invitationPPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
- Where
- Waltham
- Age
- 18 years and over
- People
- 1,500
- Run by
- CorEvitas
See details and how to joinNCT07217509 - No phaseTaking peopleAXIS MG Patient Registry
- Where
- Framingham
- Age
- 18 years and over
- People
- 1,000
- Run by
- Autoimmune Neurology Alliance
See details and how to joinNCT07761026 - No phaseTaking peoplePregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
- Where
- San Francisco
- Age
- 18 years to 64 years
- People
- 250
- Run by
- University of California, San Francisco
See details and how to joinNCT06940323 - No phaseTaking peopleMuSK Myasthenia 1000 Study
- Where
- Washington D.C.
- Age
- 7 years to 99 years
- People
- 1,000
- Run by
- George Washington University
See details and how to joinNCT06259071 - No phaseEnrolling by invitationSerum Auto-Antibodies in Neurological Diseases
- Where
- Sacramento
- Age
- 18 years and over
- People
- 120
- Run by
- University of California, Davis
See details and how to joinNCT00704626 - No phaseTaking peopleStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- Boston
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644 - No phaseTaking peopleRegistry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Where
- Augusta, Birmingham, Boston, Burlington, Chapel Hill, Charlotte, Chattanooga, Clearwater, Colorado Springs, Columbia, Dallas, Dayton, Durham, Fort Collins, Fresno, Gainesville, Houston, Iowa City, Jacksonville, Knoxville, Lansing, Lexington, Milwaukee, New Haven, New Hyde Park, Orange, Philadelphia, Rancho Mirage, Scottsdale, Sylmar, Tampa, Washington D.C.
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT04202341 - No phaseTaking peopleA Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- Where
- Morgantown
- People
- 279 worldwide
- Run by
- argenx
See details and how to joinNCT06299748 - Phase 2/3Taking peopleA Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- Where
- Denver
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Kyverna Therapeutics
See details and how to joinNCT07403188 · EU 2024-511198-31-00 - No phaseTaking peopleUnhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Where
- Delafield
- Age
- 2 years and over
- People
- 10,000
- Run by
- Brain Inflammation Collaborative
See details and how to joinNCT04806620 - No phaseTaking peopleThe EXPLORE MG Registry for Myasthenia Gravis
- Where
- New Haven
- Age
- 18 years and over
- People
- 800
- Run by
- Yale University
See details and how to joinNCT03792659 - No phaseNot yet taking people in United StatesMulti-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
- Where
- Boston
- Age
- 18 years to 80 years
- People
- 50
- Run by
- BioSensics
See details and how to joinNCT07224386 - No phaseTaking peopleVitaccess Real MG Registry
- Where
- Charleston, Houston, Lexington, Lumberton, O'Fallon, Orange
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Vitaccess Ltd
See details and how to joinNCT06064461 - No phaseTaking peopleValidation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
- Where
- Evanston
- Age
- 18 years and over
- People
- 1,000
- Run by
- ZS Associates
See details and how to joinNCT06866483 - No phaseTaking peopleMyasthenia Gravis Foundation of America Global MG Patient Registry
- Where
- Westborough
- Age
- 18 years and over
- People
- 3,800
- Run by
- Myasthenia Gravis Foundation of America
See details and how to joinNCT06617741